CoChat
Sign Up
Cited by 125Thyroid Disorders and TreatmentsOphthalmology and Eye DisordersThyroid and Parathyroid Surgery

The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.

Predicting the Likelihood of Remission in Children With Graves’ Disease: A Prospective, Multicenter Study

Glaser, Nicole S., Styne, Dennis M., for the Organization of Pediatric Endocrinologists of Northern California Collaborative Graves’ Disease Study Group·2008·Pediatrics
DOI 10.1542/peds.2007-1535
Open this paper in CoChat — free account

Abstract

OBJECTIVE. The optimal treatment for Graves’ disease in children is controversial. Antithyroid medications are often used initially, but many children eventually require alternative therapies. We evaluated predictors of remission after 2 years of antithyroid medication use. METHODS. We prospectively studied children who had Graves’ disease and were treated with antithyroid medications. We compared children who achieved remission after 2 years with those who had persistent disease to determine which variables were associated with remission; multiple logistic regression and binary recursive partitioning analyses were used to evaluate interactions among predictive variables. RESULTS. Of 51 children who completed the study, 15 (29%) achieved remission. Children who achieved remission had lower thyroid hormone concentrations at presentation than those with persistent disease (free thyroxine: 6.17 ± 3.10 vs 9.86 ± 7.54 ng/dL; total triiodothyronine: 431 ± 175 vs 561 ± 225 ng/dL). Children who achieved remission were also more likely to be euthyroid within 3 months of initiating propylthiouracil (82% vs 29%). Binary recursive partitioning analysis identified rapid achievement of euthyroid status after initiation of propylthiouracil, lower initial triiodothyronine, and older age as significant predictors of remission. CONCLUSIONS. Thyroid hormone concentrations at diagnosis, age, and initial response to propylthiouracil can be used to stratify patients according to the likelihood of remission after 2 years of antithyroid medication use. These data provide a useful guide for clinical decision-making regarding Graves’ disease in children.

Overview

Integrity signals

Registry

Crossref · 10.1542/peds.2007-1535

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 32 references

Research works printed but not linked: 2

  1. Baker B, Shapiro B, Fig L, Woodbury D, Sisson J, Beierwaltes W. Unusual complications of antithyroid drug therapy: four case reports and review of literature. Thyroidology.1989;1(1):17–26
  2. Marcocci C, Marion M. Thyroid directed antibodies. In: Braverman L, Utiger R, eds. The Thyroid. Philadelphia, PA: Lippincott Williams & Wilkins;2005:360–372

Cited by

Sorted by citations

Items 101–125 of 125

Related

See all

Metadata

Authors
Glaser, N. S., Styne, D. M., & for the Organization of Pediatric Endocrinologists of Northern California Collaborative Graves’ Disease Study Group
Affiliations
University of California, Davis (US)
ORCID
Venue
Pediatrics
Publisher
American Academy of Pediatrics (AAP)
Published
2008-03-01
Volume
121
Issue
3
Pages
e481-e488
ISSN
  • 0031-4005 (ISSN-L)
  • 1098-4275
DOI
10.1542/peds.2007-1535
OpenAlex
W2080637533
Cited by
125
References
32
Citations by year
2026: 4 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 8 · 2020: 10 · 2019: 12 · 2018: 10 · 2017: 6 · 2016: 7 · 2015: 8 · 2014: 10 · 2013: 8 · 2012: 9
FWCI
5.52
Type
journal article
Language
en
Open access
closed
Locations
  • PEDIATRICS (publishedVersion)
  • PubMed (publishedVersion)
Funders
Quest Diagnostics
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Ophthalmology › Ophthalmology and Eye Disorders
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
Keywords
Graves' disease, pediatric Graves' disease, remission prediction, antithyroid drugs, propylthiouracil, thyroid hormone levels, free thyroxine, triiodothyronine, euthyroid status, prognostic factors, age
MeSH terms
Adolescent, Age Factors, Child, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Follow-Up Studies, Graves Disease, Humans, Male, Predictive Value of Tests, Propylthiouracil, Prospective Studies, Severity of Illness Index, Sex Factors, Antithyroid Agents, Thyroid Function Tests, Multivariate Analysis, Logistic Models, Treatment Outcome, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review